Ubiquitin Proteasome pathway proteins as potential drug targets in parasite Trypanosoma cruzi

[1]  Mengqing Li,et al.  Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma , 2017, Thoracic cancer.

[2]  X. Min,et al.  ProtSecKB: The Protist Secretome and Subcellular Proteome Knowledgebase , 2016 .

[3]  Cathy H. Wu,et al.  UniProt: the universal protein knowledgebase , 2016, Nucleic Acids Research.

[4]  S. Pierrou,et al.  The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells , 2016, Scientific Reports.

[5]  P. Hotez,et al.  Status of vaccine research and development of vaccines for Chagas disease. , 2016, Vaccine.

[6]  Qi Zhao,et al.  IBS: an illustrator for the presentation and visualization of biological sequences , 2015, Bioinform..

[7]  Jorge González,et al.  Role of the Ubiquitin-Proteasome Systems in the Biology and Virulence of Protozoan Parasites , 2015, BioMed research international.

[8]  Yi Wang,et al.  OrthoVenn: a web server for genome wide comparison and annotation of orthologous clusters across multiple species , 2015, Nucleic Acids Res..

[9]  A. Ciulli,et al.  Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation , 2015, The Biochemical journal.

[10]  L. Banks,et al.  Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome , 2015, Cell Death and Disease.

[11]  Peer Bork,et al.  SMART: recent updates, new developments and status in 2015 , 2014, Nucleic Acids Res..

[12]  S. P. Kurup,et al.  The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8⁺ T cells. , 2014, Cell host & microbe.

[13]  N. Dantuma,et al.  The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution , 2014, Front. Mol. Neurosci..

[14]  R. Chari,et al.  Antibody—Drug Conjugates: An Emerging Concept in Cancer Therapy , 2014 .

[15]  S. Gannavaram,et al.  Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis , 2014, PLoS neglected tropical diseases.

[16]  T. Girke,et al.  Decoding the Ubiquitin-Mediated Pathway of Arthropod Disease Vectors , 2013, PloS one.

[17]  K. L. Le Roch,et al.  Characterization of the Ubiquitylating Components of the Human Malaria Parasite’s Protein Degradation Pathway , 2012, PloS one.

[18]  N. Rahimi.  The Ubiquitin-Proteasome System Meets Angiogenesis , 2012, Molecular Cancer Therapeutics.

[19]  C. Day,et al.  RINGs hold the key to ubiquitin transfer. , 2012, Trends in biochemical sciences.

[20]  J. Coulson,et al.  Cellular functions of the DUBs , 2012, Journal of Cell Science.

[21]  Sara Schmitt,et al.  Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy. , 2011, Current topics in medicinal chemistry.

[22]  S. Goldenberg,et al.  Analysis of Proteasomal Proteolysis during the In Vitro Metacyclogenesis of Trypanosoma cruzi , 2011, PloS one.

[23]  Robert D. Finn,et al.  HMMER web server: interactive sequence similarity searching , 2011, Nucleic Acids Res..

[24]  T. Aoki,et al.  Secretory protein with RING finger domain (SPRING) specific to Trypanosoma cruzi is directed, as a ubiquitin ligase related protein, to the nucleus of host cells , 2010, Cellular microbiology.

[25]  Bradley I. Coleman,et al.  Characterization and Structural Studies of the Plasmodium falciparum Ubiquitin and Nedd8 Hydrolase UCHL3 , 2009, The Journal of Biological Chemistry.

[26]  L. Mei,et al.  The Proteasome-Associated Deubiquitinating Enzyme Usp14 Is Essential for the Maintenance of Synaptic Ubiquitin Levels and the Development of Neuromuscular Junctions , 2009, The Journal of Neuroscience.

[27]  D. B. Weatherly,et al.  The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi , 2009, BMC Genomics.

[28]  D. Steverding,et al.  Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib , 2009, Parasites & Vectors.

[29]  Thomas Girke,et al.  Deciphering the Ubiquitin-Mediated Pathway in Apicomplexan Parasites: A Potential Strategy to Interfere with Parasite Virulence , 2008, PloS one.

[30]  M. Hochstrasser,et al.  Modification of proteins by ubiquitin and ubiquitin-like proteins. , 2006, Annual review of cell and developmental biology.

[31]  M. Maldonado,et al.  The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. , 2006, Cellular & molecular immunology.

[32]  Robert D. Finn,et al.  Pfam: clans, web tools and services , 2005, Nucleic Acids Res..

[33]  René Bernards,et al.  A Genomic and Functional Inventory of Deubiquitinating Enzymes , 2005, Cell.

[34]  K. Nakayama,et al.  Interaction of U‐box‐type ubiquitin‐protein ligases (E3s) with molecular chaperones , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[35]  R. Syljuåsen,et al.  The role of the ubiquitin/proteasome system in cellular responses to radiation , 2003, Oncogene.

[36]  Keiji Tanaka,et al.  CHIP: a quality-control E3 ligase collaborating with molecular chaperones. , 2003, The international journal of biochemistry & cell biology.

[37]  S. Elledge,et al.  Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex , 2002, Nature.

[38]  K. Nakayama,et al.  U Box Proteins as a New Family of Ubiquitin-Protein Ligases* , 2001, The Journal of Biological Chemistry.

[39]  D. Engman,et al.  International Journal for Parasitology 31 (2001) 472±481 www.parasitology-online.com Invited Review The life cycle of Trypanosoma cruzi revisited , 2001 .

[40]  V. Nussenzweig,et al.  The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. , 2001, Biochemistry.

[41]  M. Hochstrasser,et al.  Evolution and function of ubiquitin-like protein-conjugation systems , 2000, Nature Cell Biology.

[42]  D. Henríquez,et al.  Trypanosoma cruzi and human ubiquitin are immunologically distinct proteins despite only three amino acid difference in their primary sequence. , 1999, FEMS immunology and medical microbiology.

[43]  E. Corey,et al.  Proteasome activity is required for the stage-specific transformation of a protozoan parasite , 1996, The Journal of experimental medicine.

[44]  P. Freemont,et al.  Does this have a familiar RING? , 1996, Trends in biochemical sciences.

[45]  M. Scheffner,et al.  A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Donelson,et al.  Ubiquitin genes in trypanosomatidae. , 1988, The Journal of biological chemistry.

[47]  J. Coura,et al.  The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.

[48]  J. Pruneda,et al.  RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. , 2014, Biochimica et biophysica acta.

[49]  C. Patterson,et al.  The ubiquitin-proteasome system and cardiovascular disease. , 2012, Progress in molecular biology and translational science.

[50]  L. Kirchhoff.  Epidemiology of American trypanosomiasis (Chagas disease). , 2011, Advances in parasitology.

[51]  Cathy H. Wu,et al.  UniProt: the Universal Protein knowledgebase , 2004, Nucleic Acids Res..

[52]  STATUS OF IN , 2000 .